drug · Product Intelligence

Rituximab
Pipeline Intelligence

Rituximab: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
3Indexed trials
▦
3Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT02746744Anders Svenningsson · multiple_sclerosisPHASE3
NCT02950155Fredrik Piehl · neuromuscularPHASE3
NCT05332587First Affiliated Hospital, Sun Yat-Sen University · neuromuscularPHASE3

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.